NERV – Minerva Neurosciences Inc.
NERV — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
3.64
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
0.16
EPS Last/This Y
1.69
EPS This/Next Y
-0.6
Price
5.24
Target Price
9.5
Analyst Recom
2.33
Performance Q
-16.77
Upside
-19,503.0%
Beta
-0.14
Ticker: NERV
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-04-23 | NERV | 6.85 | N/A | N/A | 0 |
| 2026-04-24 | NERV | 6.56 | N/A | N/A | 0 |
| 2026-04-27 | NERV | 6.41 | N/A | N/A | 0 |
| 2026-04-28 | NERV | 6.43 | N/A | N/A | 0 |
| 2026-04-29 | NERV | 6.37 | N/A | N/A | 0 |
| 2026-04-30 | NERV | 6.45 | N/A | N/A | 0 |
| 2026-05-01 | NERV | 6.07 | N/A | N/A | 0 |
| 2026-05-04 | NERV | 6.32 | N/A | N/A | 0 |
| 2026-05-05 | NERV | 6.24 | N/A | N/A | 0 |
| 2026-05-06 | NERV | 6.21 | N/A | N/A | 0 |
| 2026-05-07 | NERV | 6.12 | N/A | N/A | 0 |
| 2026-05-08 | NERV | 5.89 | N/A | N/A | 0 |
| 2026-05-11 | NERV | 5.61 | N/A | N/A | 0 |
| 2026-05-12 | NERV | 5.58 | N/A | N/A | 0 |
| 2026-05-13 | NERV | 5.54 | N/A | N/A | 0 |
| 2026-05-14 | NERV | 5.47 | N/A | N/A | 0 |
| 2026-05-15 | NERV | 5.22 | N/A | N/A | 0 |
| 2026-05-18 | NERV | 4.71 | N/A | N/A | 0 |
| 2026-05-19 | NERV | 4.34 | N/A | N/A | 0 |
| 2026-05-20 | NERV | 5.04 | N/A | N/A | 0 |
| 2026-05-21 | NERV | 5.32 | N/A | N/A | 0 |
| 2026-05-22 | NERV | 5.25 | N/A | N/A | 0 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-04-23 | NERV | 6.84 | 74.0 | - | -0.60 |
| 2026-04-24 | NERV | 6.57 | 74.0 | - | -0.60 |
| 2026-04-27 | NERV | 6.42 | 74.0 | - | -0.60 |
| 2026-04-28 | NERV | 6.44 | 74.0 | - | -0.60 |
| 2026-04-29 | NERV | 6.36 | 74.0 | - | -0.60 |
| 2026-04-30 | NERV | 6.44 | 74.0 | - | -0.60 |
| 2026-05-01 | NERV | 6.11 | 74.0 | - | -0.60 |
| 2026-05-04 | NERV | 6.33 | 74.0 | - | -0.60 |
| 2026-05-05 | NERV | 6.23 | 74.0 | - | -0.60 |
| 2026-05-06 | NERV | 6.22 | 74.0 | - | -0.60 |
| 2026-05-07 | NERV | 6.13 | 74.0 | - | -0.60 |
| 2026-05-08 | NERV | 5.91 | 74.0 | - | -0.60 |
| 2026-05-11 | NERV | 5.62 | 58.1 | - | -0.60 |
| 2026-05-12 | NERV | 5.61 | 58.1 | - | -0.60 |
| 2026-05-13 | NERV | 5.58 | 58.1 | - | -0.60 |
| 2026-05-14 | NERV | 5.48 | 58.1 | - | -0.60 |
| 2026-05-15 | NERV | 5.21 | 58.1 | - | -0.60 |
| 2026-05-18 | NERV | 4.71 | 58.1 | - | -0.60 |
| 2026-05-19 | NERV | 4.34 | 58.1 | - | -0.60 |
| 2026-05-20 | NERV | 5.05 | 58.1 | - | -0.60 |
| 2026-05-21 | NERV | 5.32 | 58.1 | - | -0.60 |
| 2026-05-22 | NERV | 5.24 | 97.7 | - | -0.20 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-04-23 | NERV | 0.00 | 32.78 | 2.86 |
| 2026-04-24 | NERV | 0.00 | 32.78 | 2.86 |
| 2026-04-27 | NERV | 0.00 | 32.28 | 3.24 |
| 2026-04-28 | NERV | 0.00 | 32.28 | 3.24 |
| 2026-04-29 | NERV | 0.00 | 32.28 | 3.24 |
| 2026-04-30 | NERV | 0.00 | 32.28 | 3.19 |
| 2026-05-01 | NERV | 0.00 | 32.28 | 3.19 |
| 2026-05-04 | NERV | 0.00 | 32.28 | 3.19 |
| 2026-05-05 | NERV | 0.00 | 32.28 | 3.19 |
| 2026-05-06 | NERV | 0.00 | 32.28 | 3.19 |
| 2026-05-07 | NERV | 0.00 | 32.28 | 3.19 |
| 2026-05-08 | NERV | 0.00 | 32.28 | 3.00 |
| 2026-05-11 | NERV | 0.00 | 29.81 | 3.00 |
| 2026-05-12 | NERV | 0.00 | 29.81 | 3.45 |
| 2026-05-13 | NERV | 0.00 | 29.81 | 3.45 |
| 2026-05-14 | NERV | 0.00 | 29.81 | 3.45 |
| 2026-05-15 | NERV | 0.00 | 29.81 | 3.45 |
| 2026-05-18 | NERV | 0.00 | 15.72 | 3.44 |
| 2026-05-19 | NERV | 0.00 | 15.72 | 3.44 |
| 2026-05-20 | NERV | 0.00 | 15.72 | 3.44 |
| 2026-05-21 | NERV | 0.00 | 15.72 | 3.64 |
| 2026-05-22 | NERV | 0.00 | 15.72 | 3.64 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.17
Avg. EPS Est. Current Quarter
-0.01
Avg. EPS Est. Next Quarter
-0.01
Insider Transactions
Institutional Transactions
15.72
Beta
-0.14
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
27
Growth Score
17
Sentiment Score
48
Actual DrawDown %
79.1
Max Drawdown 5-Year %
-94.6
Target Price
9.5
P/E
Forward P/E
PEG
P/S
P/B
P/Free Cash Flow
EPS
-29.16
Average EPS Est. Cur. Y
-0.2
EPS Next Y. (Est.)
-0.8
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.33
Return on Equity vs Sector %
136.3
Return on Equity vs Industry %
152
EPS 1 7Days Diff
0.4
EPS 1 30Days Diff
0.4
EBIT Estimation
◆
NERV
Healthcare
$5.26
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
42.6
Range 1M
31.6%
Sup Dist
6.8%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
-87%
EPS NY
80.5%
52W%
35.4%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+80.6% upside
Upside
+80.6%
Quality
27
Minerva Neurosciences, IncSector: Healthcare
Industry: Biotechnology
Employees: 7
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, which is in Phase 3 confirmatory trial for the treatment of negative symptoms in patients with schizophrenia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.
NERV
Latest News
—
Caricamento notizie per NERV…
stock quote shares NERV – Minerva Neurosciences Inc. Stock Price stock today
news today NERV – Minerva Neurosciences Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch NERV – Minerva Neurosciences Inc. yahoo finance google finance
stock history NERV – Minerva Neurosciences Inc. invest stock market
stock prices NERV premarket after hours
ticker NERV fair value insiders trading